- Previous Close
15.40 - Open
15.56 - Bid 15.46 x --
- Ask 15.48 x --
- Day's Range
15.40 - 15.68 - 52 Week Range
10.45 - 32.56 - Volume
4,229,736 - Avg. Volume
17,875,772 - Market Cap (intraday)
1.546B - Beta (5Y Monthly) -0.08
- PE Ratio (TTM)
-- - EPS (TTM)
-2.42 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.
www.rtalabs.com.trRecent News: RTALB.IS
View MorePerformance Overview: RTALB.IS
Trailing total returns as of 12/16/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RTALB.IS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RTALB.IS
View MoreValuation Measures
Market Cap
1.54B
Enterprise Value
1.70B
Trailing P/E
35.62
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.01
Price/Book (mrq)
1.00
Enterprise Value/Revenue
14.34
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-1.89%
Return on Equity (ttm)
-47.44%
Revenue (ttm)
106.04M
Net Income Avi to Common (ttm)
-414.1M
Diluted EPS (ttm)
-2.42
Balance Sheet and Cash Flow
Total Cash (mrq)
13.58M
Total Debt/Equity (mrq)
8.92%
Levered Free Cash Flow (ttm)
-67.16M